Adil Duru

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: MOLECULAR THERAPY NUCLEIC ACIDS. 2016;5(3):e290
Lipid-based Transfection Reagents Exhibit Cryo-induced Increase in Transfection Efficiency
Sork H; Nordin JZ; Turunen JJ; Wiklander OPB; Bestas B; Zaghloul EM; Margus H; Padari K; Duru AD; Corso G; Bost J; Vader P; Pooga M; Smith CIE; Wood MJA; Schiffelers RM; Hallbrink M; Andaloussi SEL
Article: JOURNAL OF IMMUNOLOGY. 2016;196(5):2327-2334
The MHC Class I Cancer-Associated Neoepitope Trh4 Linked with Impaired Peptide Processing Induces a Unique Noncanonical TCR Conformer
Hafstrand I; Doorduijn EM; Duru AD; Buratto J; Oliveira CC; Sandalova T; van Hall T; Achour A
Article: PLOS ONE. 2015;10(9):e0138248
Deletion of Chromosomal Region 8p21 Confers Resistance to Bortezomib and Is Associated with Upregulated Decoy TRAIL Receptor Expression in Patients with Multiple Myeloma
Duru AD; Sutlu T; Wallblom A; Uttervall K; Lund J; Stellan B; Gahrton G; Nahi H; Alici E
Article: PLOS ONE. 2014;9(7):e101819
The Use of Novel Drugs Can Effectively Improve Response, Delay Relapse and Enhance Overall Survival in Multiple Myeloma Patients with Renal Impairment
Uttervall K; Duru AD; Lund J; Liwing J; Gahrton G; Holmberg E; Aschan J; Alici E; Nahi H
Article: EUROPEAN JOURNAL OF IMMUNOLOGY. 2012;42(11):2990-3000
Unexpected T-cell recognition of an altered peptide ligand is driven by reversed thermodynamics
Allerbring EB; Duru AD; Uchtenhagen H; Madhurantakam C; Tomek MB; Grimm S; Mazumdar PA; Friemann R; Uhlin M; Sandalova T; Nygren P-A; Achour A
Article: PLOS ONE. 2012;7(3):e32805
Inflammation-Associated Nitrotyrosination Affects TCR Recognition through Reduced Stability and Alteration of the Molecular Surface of the MHC Complex
Madhurantakam C; Duru AD; Sandalova T; Webb JR; Achour A
Article: PLOS ONE. 2010;5(10):e13174
Natural Killer Cell Tolerance Persists Despite Significant Reduction of Self MHC Class I on Normal Target Cells in Mice
Brodin P; Lakshmikanth T; Mehr R; Johansson MH; Duru AD; Achour A; Salmon-Divon M; Karre K; Hoglund P; Johansson S
Article: CELLULAR SIGNALLING. 2010;22(10):1523-1535
Analysis of the Wnt/B-catenin/TCF4 pathway using SAGE, genome-wide microarray and promoter analysis: Identification of BRI3 and HSF2 as novel targets
Kavak E; Najafov A; Ozturk N; Seker T; Cavusoglu K; Aslan T; Duru AD; Saygili T; Hoxhaj G; Hiz MC; Unal DO; Birgul-Iyison N; Ozturk M; Koman A
Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2005;280(14):13701-13711
Triticum durum metallothionein. Isolation of the gene and structural characterization of the protein using solution scattering and molecular modeling.
Bilecen K; Ozturk UH; Duru AD; Sutlu T; Petoukhov MV; Svergun DI; Koch MHJ; Sezerman UO; Cakmak I; Sayers Z

Alla övriga publikationer

Letter: BRITISH JOURNAL OF HAEMATOLOGY. 2016;174(3):473-477
Re-challenging with anti-CD38 monotherapy in triple-refractory multiple myeloma patients is a feasible and safe approach
Alici E; Chrobok M; Lund J; Ahmadi T; Khan I; Duru AD; Nahi H
Review: FRONTIERS IN IMMUNOLOGY. 2015;6:605
Natural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor Activity
Dahlberg CIM; Sarhan D; Chrobok M; Duru AD; Alici E
Meeting abstract: CANCER RESEARCH. 2013;73:b41
Analysis of immune responses and tumor protection in C57/Bl6 mice immunized with altered CD8 survivin peptide ligands.
de Coana YP; Duru AD; Lladser A; Achour A; Kiessling R
Meeting abstract: MOLECULAR IMMUNOLOGY. 2012;51(1):33-34
Enhanced immunogenicity of MHC class I-restricted tumor-associated altered peptide ligands
Uchtenhagen H; Stahl E; Duru AD; Tolba E; Celie P; Springer S; van Hall T; Schumacher TN; Achour A

Anställningar

Anknuten till Forskning, Medicin, Solna, Karolinska Institutet, 2025-2028

Examina och utbildning

Medicine Doktorsexamen, Institutionen för medicin, Huddinge, Karolinska Institutet, 2012

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI